Is Now The Perfect Time To Buy AstraZeneca plc, Imagination Technologies Group plc And BHP Billiton plc?

Should you add these 3 stocks to your portfolio? AstraZeneca plc (LON: AZN), Imagination Technologies Group plc (LON: IMG) and BHP Billiton plc (LON: BLT)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

All companies have periods where their financial performance is somewhat disappointing. That is just the nature of business and, while it can mean a fall in the company’s share price in the short term, it can also lead to major changes at the company which puts it on a stronger footing for the long term. And, for investors willing to take a risk on such a stock, the rewards can be hugely enticing.

For example, AstraZeneca (LSE: AZN) has endured a torrid time in recent years, with a number of its key, blockbuster drugs losing their patent protection. This has led to falling sales as generic competition grabs market share and, as a result, AstraZeneca’s top line has fallen from just under £22bn in 2011 to a forecast of less than £16bn in the current year. And, while cost cuts and efficiencies have been made, AstraZeneca’s earnings have also tumbled by over 40% during the same time period.

However, AstraZeneca has made major changes to its business so as to position itself for future growth. Notably, it has engaged in considerable M&A activity, which has boosted its pipeline and caused market sentiment to improve as investors begin to factor in potential earnings growth from 2017 onwards. Furthermore, AstraZeneca has shifted its focus towards treatments for conditions such as diabetes that offer huge growth potential in the coming decades, thereby setting the company up for upbeat ultra-long term growth potential.

Despite its share price having risen by 49% since the start of 2013, AstraZeneca still offers excellent value for money. For example, it trades on a price to earnings (P/E) ratio of 15.7 and has a dividend yield of 4.2%; both of which indicate that now is a great time to buy a slice of the pharmaceutical play.

Similarly, BHP Billiton (LSE: BLT) has also endured a challenging period, with the prices of commodities tumbling and causing its earnings to decline by 52% last year. And, in the current year, they are forecast to fall by a further 33% which, in the short run, could hurt investor sentiment.

However, with BHP spinning off non-core assets, cutting costs and generating efficiencies, it appears to be addressing the challenges which it faces. This, in the long run, could leave it in a stronger position relative to its peers and lead to much improved profitability in the coming years. Certainly, a P/E ratio of 20.8 is hardly cheap but, for one of the largest and best diversified mining stocks in the world, it appears to be a price worth paying for sound long term growth prospects.

Meanwhile, Imagination Technologies (LSE: IMG) today announced a profit warning for the first half of the current year. It is blaming a slowdown in the semiconductor sector, with reduced demand from emerging markets being a key cause. As such, it expects to post a loss in the first half of the year. And, while the company expects the second half of the year to be a major improvement, it has stated that it may not fully offset a tough first half of the year.

Due to the profit warning, shares in Imagination Technologies are down by over 10% today. Clearly, this is disappointing for the company’s investors but, realistically, it is most likely to be a weak six-month period rather than the start of a prolonged period of decline. Furthermore, with Imagination Technologies being forecast to increase its earnings at a double-digit rate next year, it remains a very enticing growth stock which, for long term investors, is now trading at an even more appealing share price.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of AstraZeneca and BHP Billiton. The Motley Fool UK owns shares of Imagination Technologies. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »